BidaskClub upgraded shares of Atrion (NASDAQ:ATRI) from a buy rating to a strong-buy rating in a research note published on Friday morning.
Shares of NASDAQ ATRI opened at $722.11 on Friday. Atrion has a 12 month low of $516.85 and a 12 month high of $734.90. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 38.40 and a beta of 0.56.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 17th. Shareholders of record on Monday, December 3rd will be issued a $1.35 dividend. The ex-dividend date of this dividend is Friday, November 30th. This represents a $5.40 annualized dividend and a yield of 0.75%.
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Further Reading: What is insider trading?
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.